Cargando…

P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY

Detalles Bibliográficos
Autores principales: Chantepie, Sylvain, Huguet, Françoise, Hunault, Mathilde, Roth Guepin, Gabrielle, Balsat, Marie, Pilar Gallego Hernanz, Maria, Joris, Magalie, Karangwa, Alexandre, Ojeda Uribe, Mario, Santagostino, Alberto, Maury, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429023/
http://dx.doi.org/10.1097/01.HS9.0000968516.29905.4e
_version_ 1785090611879084032
author Chantepie, Sylvain
Huguet, Françoise
Hunault, Mathilde
Roth Guepin, Gabrielle
Balsat, Marie
Pilar Gallego Hernanz, Maria
Joris, Magalie
Karangwa, Alexandre
Ojeda Uribe, Mario
Santagostino, Alberto
Maury, Sébastien
author_facet Chantepie, Sylvain
Huguet, Françoise
Hunault, Mathilde
Roth Guepin, Gabrielle
Balsat, Marie
Pilar Gallego Hernanz, Maria
Joris, Magalie
Karangwa, Alexandre
Ojeda Uribe, Mario
Santagostino, Alberto
Maury, Sébastien
author_sort Chantepie, Sylvain
collection PubMed
description
format Online
Article
Text
id pubmed-10429023
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104290232023-08-17 P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY Chantepie, Sylvain Huguet, Françoise Hunault, Mathilde Roth Guepin, Gabrielle Balsat, Marie Pilar Gallego Hernanz, Maria Joris, Magalie Karangwa, Alexandre Ojeda Uribe, Mario Santagostino, Alberto Maury, Sébastien Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429023/ http://dx.doi.org/10.1097/01.HS9.0000968516.29905.4e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Chantepie, Sylvain
Huguet, Françoise
Hunault, Mathilde
Roth Guepin, Gabrielle
Balsat, Marie
Pilar Gallego Hernanz, Maria
Joris, Magalie
Karangwa, Alexandre
Ojeda Uribe, Mario
Santagostino, Alberto
Maury, Sébastien
P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
title P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
title_full P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
title_fullStr P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
title_full_unstemmed P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
title_short P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
title_sort p402: inotuzumab ozogamicin treatment in adult patients with relapsed or refractory philadelphia chromosome-negative cd22-positive b-cell precursor acute lymphoblastic leukemia: a real-life french study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429023/
http://dx.doi.org/10.1097/01.HS9.0000968516.29905.4e
work_keys_str_mv AT chantepiesylvain p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT huguetfrancoise p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT hunaultmathilde p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT rothguepingabrielle p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT balsatmarie p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT pilargallegohernanzmaria p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT jorismagalie p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT karangwaalexandre p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT ojedauribemario p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT santagostinoalberto p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy
AT maurysebastien p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy